We Can Medicines Co., Ltd.

6929 · TWO · Consumer Defensive / Packaged Foods

20.95TWD-0.20 (-0.95%)

Price History

Full chart

Market Stats

Previous Close21.15

Open20.45

Day Range20.45 – 20.95

52-Week Range20.50 – 36.50

Volume2.00K

Market Cap1.01B

P/E (TTM)0.00

Forward P/E0.00

EPS-1.73

Dividend Yield0.00%

Beta-0.61

50-Day Avg22.58

200-Day Avg26.97

About

We Can Medicines Co., Ltd. operates a chain of drug stores in Taiwan. The company offers medicine, health food, maternal and baby product, beauty care products, and medical equipment. It sells its products through retail stores and online under the VITALPLUS and Sapporo brands. The company was formerly known as Shenglin Pharmaceutical Co., Ltd. The company was founded in 1972 and is headquartered in Taichung, Taiwan. We Can Medicines Co., Ltd. operates as a subsidiary of Yousheng Medical Technology Co., Ltd.

Company Details

SectorConsumer Defensive
IndustryPackaged Foods
CEODe-Lan Wen
Employees1.02K
HeadquartersNo. 925, Taiwan Avenue, Taichung, Taiwan, Taiwan
Websitehttps://www.yourchance.com.tw

Leadership

De-Lan WenGeneral Manager
Mei Fang ZhuangAccounting Supervisor

Financials

Income Statement

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	2.79B	3.30B	3.12B	3.27B	3.22B
Growth (%)	-	+18.21%	-5.45%	+4.69%	-1.45%
Cost of Revenue	1.88B	2.19B	2.10B	2.17B	2.15B
Gross Profit	916.55M	1.11B	1.02B	1.10B	1.07B
Gross Margin	32.80%	33.66%	32.77%	33.77%	33.15%
Operating Expense	886.13M	990.45M	1.00B	1.15B	1.14B
Operating Income	30.42M	121.14M	21.54M	-50.13M	-67.72M
Operating Margin	1.09%	3.67%	0.69%	-1.53%	-2.10%
EBITDA	-	393.76M	321.25M	288.21M	273.11M
EBITDA Margin	-	11.92%	10.29%	8.82%	8.48%
Net Income	38.79M	100.05M	14.80M	-47.18M	-73.21M
Net Income Margin	1.39%	3.03%	0.47%	-1.44%	-2.27%
Interest Expense	14.43M	19.09M	23.46M	27.43M	25.60M
Interest Expense % of Total Revenue	0.52%	0.58%	0.75%	0.84%	0.79%

Balance Sheet

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	2.21B	2.58B	2.86B	3.09B	2.98B
Total Liabilities	1.53B	1.78B	2.04B	1.97B	1.93B
Total Equity	684.54M	791.69M	816.35M	1.12B	1.05B
Cash	203.36M	216.26M	160.53M	305.67M	245.36M
Net Debt	-	-	121.19M	-	-

Cash Flow

Currency: TWD	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	457.15M	346.67M	139.84M	260.68M	240.02M
Capital Expenditure	342.95M	122.92M	93.95M	69.24M	35.92M
Free Cash Flow	114.20M	223.75M	45.89M	191.44M	204.10M
Dividends Paid	-	-	-	12.00M	-
FCF to OCF	24.98%	64.54%	32.81%	73.44%	85.03%
Dividend Paid to FCF	-	-	-	6.27%	-

Earnings

Report Date	Aug 14, 2024	Nov 11, 2024
EPS Estimate	0.15	-
EPS Actual	-0.08	-0.47
Surprise	-153.33%	-
Timing	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap1.01B

Enterprise Value1.88B

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.31

Price / Book0.99

EPS-1.73

Book Value22.36

Revenue (TTM)3.21B

Gross Profit (TTM)1.05B

EBITDA-11.02M

Profit Margin-2.43%

Operating Margin-1.63%

Return on Equity-7.40%

Return on Assets-1.62%

Shares Outstanding45.09M

Shares Float4.98M

Beta-0.61

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20241×

0.27Aug 1, 2024